Home » Authors » Rainer B. Langen

Articles by Rainer B. Langen

MediGene Gains European Rights To Atrix's Leuprogel Product Line

April 11, 2001

By Rainer B. Langen

Cardion Acquires Tolerance For Immunotherapy Platform

April 11, 2001

By Rainer B. Langen

Micromet Raises EUR40M In Fourth Financing Round

April 4, 2001

By Rainer B. Langen

Morphochem Enters Alliances With Aventis Pharma, Sosei

March 28, 2001

By Rainer B. Langen

Schering AG Spins Off Biotech Unit With Funding From Apax

March 21, 2001

By Rainer B. Langen

Germany Grants DM150M For Bioinformatics, Genomics Work

March 14, 2001

By Rainer B. Langen

LION Branching Into Data Area Via Equity Investment In GMD

Feb. 28, 2001

By Rainer B. Langen

G.O.T., atugen Collaborate On Lipids To Knock Down Genes

Feb. 28, 2001

By Rainer B. Langen

Curacyte Gets Into Full Swing With US$6.5M Seed Financing

Feb. 14, 2001

By Rainer B. Langen

GeneScan, Motorola Developing Device For On-Site DNA Analysis

Feb. 7, 2001

By Rainer B. Langen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...